Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,284.00
(
0.63%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.96
(
-0.69%
)
Bitcoin
74,075.34
(
0.18%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: mcbio post# 87700

Thursday, 12/17/2009 5:42:02 PM

Thursday, December 17, 2009 5:42:02 PM

Post# of 257253
PYMX MNTA:

why couldn't PMX-60056 theoretically be partnered with SNY or, better yet, Sandoz/MNTA?

The commercial benefit of having reversibility data would accrue not only to branded Lovenox, but also to any substitutable generic and vice-versa. Hence, if SNY or NVS sponsored a PMX-60056 program, they would be helping their competitor as much as they would be helping themselves.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now